CRCRANE COMPANYLarge cap · $12.46B · FY ending 2025-12-31
$215.85-1.47% · 2026-07-13 · EOD
58/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality61
narrow moat · ROIC 11%Value39
P/E 34.5 · 88% of 12-mo rangeMomentum62
golden · price above 200-daySmart Money71
buying · 1 funds · 1P/1S insidersBullish stackGolden cross (fresh)Above 200-day
vs S&P 500-0.2%
6-mo excess Trailing performance1M +10.3%
3M +14.5%
6M +8.4%
YTD +15.1%
1Y +15.5%
P/E vs its last 12 months (our price history): 25.7 low → 35.7 high
Current price sits at the 88th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Narrow moat — ROIC 11%
Piotroski F3/9
fundamental strength Altman ZSafe
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 23%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio14.4%
comfortable Shareholder yield0.4%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying1P / 1S insiders · 1 funds hold · 0 Congress buys
Recent insidersLynch Susan D · DirectorBUY$26,607
Feldman Jason D. · SVP, IR, Treasury & TaxSELL$543,851
Fund holders (13F)GAMCO Investors (Mario Gabelli)$170.7M1.7% of book
Bhealth · 74/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.